Published in J Cereb Blood Flow Metab on June 01, 2003
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain (2007) 2.04
Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol (2010) 2.04
Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke (2011) 1.96
Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke (2009) 1.72
Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab (2010) 1.46
Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation (2012) 1.40
Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci (2009) 1.38
Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol (2011) 1.23
The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood. Brain Res (2008) 1.23
A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci U S A (2004) 1.23
Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab (2010) 1.22
Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke (2009) 1.18
Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats. J Neurotrauma (2010) 1.17
Protein design: toward functional metalloenzymes. Chem Rev (2014) 1.17
Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol (2008) 1.14
Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation (2013) 1.14
Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury. Neurobiol Dis (2011) 1.12
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res (2013) 1.10
Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem (2009) 1.10
The relationship between hematoma iron content and perihematoma edema: an MRI study. Cerebrovasc Dis (2009) 1.09
Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech (2012) 1.09
Cerebroprotective functions of HO-2. Curr Pharm Des (2008) 1.07
Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci (2014) 1.05
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care (2013) 1.04
Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog Neurobiol (2013) 1.03
Intracranial hemorrhage: mechanisms of secondary brain injury. Acta Neurochir Suppl (2011) 1.03
Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage. J Cereb Blood Flow Metab (2014) 1.00
Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS (2014) 1.00
Rodent neonatal germinal matrix hemorrhage mimics the human brain injury, neurological consequences, and post-hemorrhagic hydrocephalus. Exp Neurol (2012) 1.00
Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes. J Cereb Blood Flow Metab (2008) 0.99
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis (2010) 0.96
C3a receptor antagonist attenuates brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab (2008) 0.95
Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage. J Cereb Blood Flow Metab (2008) 0.95
Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential. Transl Stroke Res (2013) 0.95
The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol (2009) 0.94
Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin. Neurobiol Dis (2008) 0.94
Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance. J Neurochem (2014) 0.93
Evaluation of brain iron content based on magnetic resonance imaging (MRI): comparison among phase value, R2* and magnitude signal intensity. PLoS One (2012) 0.92
Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm (2010) 0.92
Brain alpha- and beta-globin expression after intracerebral hemorrhage. Transl Stroke Res (2010) 0.91
Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH. Transl Stroke Res (2013) 0.91
Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron. Neurosci Res (2008) 0.90
Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin (2014) 0.90
Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation. J Neurosci Res (2010) 0.90
Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna) (2013) 0.90
Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage. J Cereb Blood Flow Metab (2010) 0.90
Intracerebral hemorrhage: a multimodality approach to improving outcome. Transl Stroke Res (2014) 0.89
Bilirubin oxidation products, oxidative stress, and intracerebral hemorrhage. Acta Neurochir Suppl (2008) 0.88
A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system. Med Hypotheses (2009) 0.88
Apotransferrin protects cortical neurons from hemoglobin toxicity. Neuropharmacology (2010) 0.87
Regulation of ROS production and vascular function by carbon monoxide. Oxid Med Cell Longev (2012) 0.87
Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression. Acta Pharmacol Sin (2015) 0.84
Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage. Brain Res (2016) 0.83
A rapid fluorescent method to quantify neuronal loss after experimental intracerebral hemorrhage. J Neurosci Methods (2013) 0.83
Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB. CNS Neurosci Ther (2014) 0.83
Iron-induced necrotic brain cell death in rats with different aerobic capacity. Transl Stroke Res (2015) 0.83
Role of lipocalin-2 in brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab (2015) 0.81
CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage. Neural Regen Res (2016) 0.80
Increased expression of ferritin in cerebral cortex after human traumatic brain injury. Neurol Sci (2012) 0.80
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2. Stroke (2015) 0.80
Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage. Mol Neurobiol (2016) 0.79
Intercellular cross-talk in intracerebral hemorrhage. Brain Res (2015) 0.79
Protective effect of hydrogen gas therapy after germinal matrix hemorrhage in neonatal rats. Acta Neurochir Suppl (2011) 0.79
A preliminary study of metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS. J Proteome Res (2008) 0.79
A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. Sci Rep (2016) 0.78
Bilirubin and its oxidation products damage brain white matter. J Cereb Blood Flow Metab (2014) 0.78
3D finite compartment modeling of formation and healing of bruises may identify methods for age determination of bruises. Med Biol Eng Comput (2010) 0.78
Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol Aging (2006) 0.78
Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage. J Neuroinflammation (2016) 0.77
Neuroprotection by melatonin after germinal matrix hemorrhage in neonatal rats. Acta Neurochir Suppl (2011) 0.77
Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity. Neurotoxicology (2014) 0.77
Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol (2016) 0.77
Antioxidant strategies in neurocritical care. Neurotherapeutics (2012) 0.76
Hck Promotes Neuronal Apoptosis Following Intracerebral Hemorrhage. Cell Mol Neurobiol (2016) 0.76
A new method to image heme-Fe, total Fe, and aggregated protein levels after intracerebral hemorrhage. ACS Chem Neurosci (2015) 0.75
Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cells. Intensive Care Med Exp (2015) 0.75
Curcumin inhibits appoptosin-induced apoptosis via upregulating heme oxygenase-1 expression in SH-SY5Y cells. Acta Pharmacol Sin (2015) 0.75
Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? Mech Ageing Dev (2016) 0.75
New avenues for treatment of intracranial hemorrhage. Curr Treat Options Cardiovasc Med (2014) 0.75
Hepcidin Protects Neuron from Hemin-Mediated Injury by Reducing Iron. Front Physiol (2017) 0.75
Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage. Nat Commun (2017) 0.75
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab (2009) 2.85
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J Neurosci (2002) 2.12
Creatine kinase is associated with failure of hypertension treatment. J Hypertens (2013) 2.02
Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci (2004) 1.94
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke (2012) 1.77
Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics (2009) 1.73
Gene expression profiling of blood for the prediction of ischemic stroke. Stroke (2010) 1.61
Gene expression changes in children with autism. Genomics (2007) 1.55
Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat. Stroke (2004) 1.54
Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem (2002) 1.52
Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem (2002) 1.52
Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab (2008) 1.50
Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol (2010) 1.50
Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev (2004) 1.46
Resistance artery creatine kinase mRNA and blood pressure in humans. Hypertension (2013) 1.46
Hypoxic preconditioning protects against ischemic brain injury. NeuroRx (2004) 1.44
Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics (2006) 1.39
Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci (2002) 1.37
Blood biomarkers of ischemic stroke. Neurotherapeutics (2011) 1.34
Heterogeneity in the penumbra. J Cereb Blood Flow Metab (2011) 1.33
Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.32
Hypoxia preconditioning in the brain. Dev Neurosci (2005) 1.30
Brain genomics of intracerebral hemorrhage. J Cereb Blood Flow Metab (2006) 1.30
Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol (2010) 1.26
Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res (2008) 1.25
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann Neurol (2004) 1.25
Empirical Bayes accomodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients. BMC Genomics (2008) 1.24
Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci (2003) 1.20
Effects of gender on gene expression in the blood of ischemic stroke patients. J Cereb Blood Flow Metab (2011) 1.20
Profiles of lacunar and nonlacunar stroke. Ann Neurol (2011) 1.19
Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology (2005) 1.15
Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2006) 1.14
Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol (2005) 1.11
Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2005) 1.10
Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab (2003) 1.10
Is creatine kinase the intrinsic factor of smooth muscle enhancing vascular contractility in subjects of african ancestry? Hypertension (2013) 1.09
SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke (2007) 1.08
Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain Res (2004) 1.08
Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats. Stroke (2010) 1.08
Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS One (2011) 1.06
Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons. Neurobiol Dis (2008) 1.05
The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke (2011) 1.05
Creatine kinase activity is associated with blood pressure. Circulation (2006) 1.04
Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J Cereb Blood Flow Metab (2009) 1.02
N-acetylaspartate as a reservoir for glutamate. Med Hypotheses (2006) 1.02
A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: a preliminary report. Am J Med Genet B Neuropsychiatr Genet (2007) 1.02
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles? Transl Stroke Res (2011) 1.01
Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol (2007) 1.00
Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes. J Cereb Blood Flow Metab (2008) 0.99
Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke (2010) 0.99
Molecular identification of the ischemic penumbra. Stroke (2004) 0.98
Ethnic differences in tissue creatine kinase activity: an observational study. PLoS One (2012) 0.98
The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review. PLoS One (2013) 0.98
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J Clin Invest (2012) 0.96
Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord. J Neurotrauma (2004) 0.95
Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells. Gene (2012) 0.95
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
17-beta-estradiol induces heat shock proteins in brain arteries and potentiates ischemic heat shock protein induction in glia and neurons. J Cereb Blood Flow Metab (2002) 0.92
Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache (2004) 0.92
Differential cerebral protein synthesis and heat shock protein 70 expression in the core and penumbra of rat brain after transient focal ischemia. Neurosurgery (2003) 0.92
Training the developing brain, part I: cognitive developmental considerations for training youth. Curr Sports Med Rep (2013) 0.91
RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol (2013) 0.91
Gene expression profiling of blood in brain arteriovenous malformation patients. Transl Stroke Res (2011) 0.90
Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage. J Cereb Blood Flow Metab (2010) 0.90
Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol (2009) 0.89
Age-related gene expression in Tourette syndrome. J Psychiatr Res (2008) 0.89
Genome response to tissue plasminogen activator in experimental ischemic stroke. BMC Genomics (2010) 0.89
Bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs. J Neurosurg (2004) 0.89
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem (2010) 0.88
Do current animal models of intracerebral hemorrhage mirror the human pathology? Transl Stroke Res (2010) 0.88
Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab (2002) 0.88
A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system. Med Hypotheses (2009) 0.88
GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: a pilot study. Brain Res (2011) 0.87
Exon expression and alternatively spliced genes in Tourette Syndrome. Am J Med Genet B Neuropsychiatr Genet (2010) 0.87
Ischemic transient neurological events identified by immune response to cerebral ischemia. Stroke (2012) 0.87
A prototype device for non-invasive continuous monitoring of intracerebral hemorrhage. J Neurosci Methods (2012) 0.87
Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J Dev Behav Pediatr (2005) 0.87
Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. Neuropsychopharmacology (2005) 0.87
An in vitro model of aneurysmal subarachnoid hemorrhage: oxidation of unconjugated bilirubin by cytochrome oxidase. J Neurochem (2007) 0.86
Gene expression in blood of subjects with Duchenne muscular dystrophy. Neurogenetics (2008) 0.86
Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage. Transl Stroke Res (2012) 0.85
Regional genome transcriptional response of adult mouse brain to hypoxia. BMC Genomics (2011) 0.85
Role of bilirubin oxidation products in the pathophysiology of DIND following SAH. Acta Neurochir Suppl (2013) 0.85
Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders. Mol Autism (2013) 0.85